0001062993-11-001099.txt : 20110322
0001062993-11-001099.hdr.sgml : 20110322
20110322170124
ACCESSION NUMBER: 0001062993-11-001099
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20100608
FILED AS OF DATE: 20110322
DATE AS OF CHANGE: 20110322
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gitman Paul
CENTRAL INDEX KEY: 0001375378
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34236
FILM NUMBER: 11704463
MAIL ADDRESS:
STREET 1: 167 EXECUTIVE DRIVE
CITY: MANHASSET HILLS
STATE: NY
ZIP: 11040
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0000875622
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113054851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 WILBUR ST
CITY: LYNBROOK
STATE: NY
ZIP: 11563
BUSINESS PHONE: 5165937000
MAIL ADDRESS:
STREET 1: 35 WILBUR STREET
CITY: LYNBROOK
STATE: NY
ZIP: 11563
4/A
1
form4a.xml
AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0303
4/A
2010-06-08
2010-06-10
0000875622
BIOSPECIFICS TECHNOLOGIES CORP
BSTC
0001375378
Gitman Paul
167 EXECUTIVE DRIVE
MANHASSET HILLS
NY
11040
1
0
0
0
Common Stock
2010-06-08
4
M
0
5425
1.00
A
41425
D
Stock Option (Right to Buy)
1.00
2010-06-08
4
M
0
5425
0
D
2002-09-30
2012-09-29
Common Stock, $.001 par value
5425
159000
D
This item has been revised from "5,452" to "5,425" to reflect the correct amount of securities acquired.
This item has been revised from "41,452" to "41,425" to reflect the correct amount of securities beneficially owned following the reported transaction.
This item has been revised from "5,452" to "5,425" to reflect the correct amount of options exercised.
This item has been revised from "158,973" to "159,000" to reflect the correct number of derivative securities beneficially owned following the reported transaction.
This amendment to the Form 4 previously filed on June 10, 2010 is being filed solely to correct typographical errors set forth in Tables I and II as described above.
/s/ Paul Gitman by Carl A. Valenstein, attorney in fact
2011-03-22